Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT

Clinical trial NCT03515096 · COMPLETED

Trial details

NCT number: NCT03515096
Sponsor: Shenzhen Second People's Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Eltrombopag Hematopoietic Stem Cell Transplantation Thrombocytopenia

Start date: 2018-07-01
Primary completion: 2021-08-02
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.